4//SEC Filing
Degnan Chris 4
Accession 0001437749-25-030772
CIK 0001668243other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 1:37 PM ET
Size
8.2 KB
Accession
0001437749-25-030772
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-10-08+4,483→ 4,483 total - Sale
Ordinary Shares
2025-10-08$16.85/sh−2,203$37,121→ 2,280 total - Exercise/Conversion
Restricted Stock Units
2025-10-08−4,483→ 8,967 total→ Ordinary Shares (4,483 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 1:37 PM ET
- Size
- 8.2 KB